Lipid Regulating Drugs and Anti-artherosclerosis Drugs Repor

【?2008-08-05 發(fā)布?】　美迪醫(yī)訊

Lipid Regulating Drugs and Anti-artherosclerosis Drugs Report

Market Research Report On Lipid Regulating Drugs and Anti-artherosclerosis Drugs

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd

Published: July 2006

Format: Hardcopy and Adobe PDF

Price: US$3,500

Contact: Mr.Humphrey

Tel.: 86-10-58110925 Fax: 86-10-58110918

E-mail: hhuang@medicexchange.com

First part: Epidemiology of hyperlipemia

1 Conception of hyperlipemia

2 Types of hyperlipemia

3 Epidemiology of hyperlipemia in China

3.1 Chinese blood-lipid level and distribution feature

3.2 Morbidity rate

4 Catergories and product structure

5 Overview of Health food for lipids regulating

Second part: Market analysis

1 Market scale and growth trend of cardiovascular drugs

2 Overview about lipids regulating drugs marekt

2.1 Academic market capacity

2.2 Overview about hospital market and retail market

3 Analysis about hospital market

3.1 Growth trend of lipids regulating drugs in the past few years

3.2 Market shares of different categories

3.3 Sales rank of breeds of lipids regulating drugs last year

3.4 Sales analysis in key cities

3.5 Sales analysis of Statin drugs

3.5.1 Simvastatin(Zocor)

3.5.2 Lovastatin(Mevacor)

3.5.3 Pravastatin

3.5.4 Fluvastatin(Lescol)

3.5.5 Atorvastatin

3.5.6 Rosuvastatin

3.5.7 Compound preparation of Statins

ezetimibe/Simvastatin （Vytorin）

Torcetrapib/Atorvastatin

MK-0524A/Zocor

Statins+cholalic acid chelating agent

Other compound preparation of Statins

3.6 Fibrates

3.6.1 Fenofibrate

3.6.2 Gemfibrozil

3.7 Nicotinic Acid class

3.7.1 Tocopheryl Nicotinate

3.7.2 Acipimox

3.8 Prepared Chinese Medicine

3.8.1 "ZhiBiTuo"

3.8.2 "XueZhiKang"

3.8.3 Gypenosides

3.9 Heparins class

3.9.1 Chondroitin A

3.9.2 Alginic　Sodium　Diester

3.9.3 Mannose　Ester

3.10 Polyunsaturated fatty acid class

3.10.1 Ethyl　Polyenoate

3.10.2 Squalene

3.10.3 Linoleic acid compound

3.10.4 Evening primrose oil

3.11 Analysis about manufacturing enterprises

3.11.1 Market share of procucts made by domestic, foreign, joint venture enterprises

3.11.2 Top 15 manufacturing enterprising last year

4 Analysis about retail market

4.1 Market shares of different categories

4.2 Sales rank of breeds of lipids regulating drugs

4.3 Sales shares of different enterprises

4.3.1 Statins

4.3.2 Prepared Chinese Medicine

4.3.3 Fibrates

4.3.4 Polyunsaturated fatty acid class

4.3.5 Nicotinic Acid class

4.4 Enterprise list ranked by sales value

4.5 Top 15 enterpsies ranked by sales value in different cities

4.5.1 Beijing

4.5.2 Shanghai

4.5.3 Guangzhou

4.5.4 Wuhan

4.5.5 Shenyang

4.5.6 chengdu

4.5.7 hangzhou

4.5.8 Shenzhen

4.5.9 Shijiazhuang

4.5.10 Zhengzhou

本文關(guān)鍵字:

收藏本文到:

《美迪醫(yī)訊》歡迎您參與新聞投稿，業(yè)務(wù)咨詢：美迪醫(yī)療網(wǎng)業(yè)務(wù)咨詢

我要評(píng)論：《Lipid Regulating Drugs and Anti-artherosclerosis Drugs Repor》
匿名發(fā)表我的名字: Email: 驗(yàn)證碼:

《上海醫(yī)療器械批發(fā)》產(chǎn)品推薦

斯曼峰電動(dòng)吸引器YX932D 廠價(jià)：¥1350元	雅博防褥瘡充氣床墊DOMUS 2 廠價(jià)：¥1800元
棱牌（米沙瓦）一次性使用無菌注射器廠價(jià)：¥60元	滬通高頻電刀GD350-B 廠價(jià)：¥30800元
斯曼峰電動(dòng)洗胃機(jī)DXW-A 廠價(jià)：¥2600元	康德萊一次性使用無菌注射針30G 廠價(jià)：¥0.35元
德國(guó)貝朗動(dòng)靜脈留置針I(yè)ntrocan-W英初康帶翼廠價(jià)：¥6.8元	飛利浦自動(dòng)體外除顫器HS1 廠價(jià)：¥39000元

国产精品亚洲欧美大片在线看 ,久久久久成人片免费观看蜜芽 ,精品国产乱码久久久久久郑州公司

Lipid Regulating Drugs and Anti-artherosclerosis Drugs Repor

Lipid Regulating Drugs and Anti-artherosclerosis Drugs Report

《美迪醫(yī)訊》歡迎您參與新聞投稿，業(yè)務(wù)咨詢： 美迪醫(yī)療網(wǎng)業(yè)務(wù)咨詢

《美迪醫(yī)訊》歡迎您參與新聞投稿，業(yè)務(wù)咨詢：美迪醫(yī)療網(wǎng)業(yè)務(wù)咨詢